Anpac Bio-Medical Science Company

Description

• Anpac Bio-Medical Science Company, Ltd., is led by award-winning and internationally respected biomedical and nanotechnology scientists, research and medical professionals, engineering experts and physicists -- creating and launching break-through, leading edge, early cancer and other disease screening, detection, and diagnostic technology. Anpacs Cancer Differentiation Analysis (CDA) technology incorporates proprietary, in-vivo (or non-invasive) screening and diagnostics devices that measure simple, Blood Biopsies -- assessing multiple microscopic parameters in whole blood samples, often identifying cancer pre-Stage One. Comprehensive research validity data from over 30,000 cases to date indicate Anpacs CDA screening and diagnostics far exceed existing or competing disease screening technologies - revealing a consistent sensitivity and specificity rate range of 70%-95% for over 16 different types of cancer to date. And it does so without any harmful side effects in patients; generating far fewer false positives; and at a cost substantially lower than traditional testing (such as imaging). Anpac Bio-Medical is an international company promoting a corporate culture of creativity, teamwork, balance, and commitment to excellence, family, and social responsibility. For more information regarding Anpac Bio-Medical Science Company, please check: www.AnpacBio.com.
• 

  Headquarters:2260 Clove Drive , San Jose, California, United States

  More
• 

  Phone Number: +1 267-810-6776

• 

  Website: https://www.anpacbio.com

• 

  Employees:10

• 

  Revenue:$1 - 10M

• 

  Legal Name:Anpac Bio-Medical Science Company

• Anpac Bio-Medical Science Company's Social Media

  
• Is this data correct?

• |  NAICS Code: 332994  |

  Show More